Q2 2023 13F Holders as of 30 Jun 2023
-
Type / Class
-
Equity / Common Shares
-
Shares outstanding
-
80.1M
-
Number of holders
-
76
-
Total 13F shares, excl. options
-
3.89M
-
Shares change
-
-71.1K
-
Total reported value, excl. options
-
$13.9M
-
Value change
-
-$142K
-
Put/Call ratio
-
0.06
-
Number of buys
-
19
-
Number of sells
-
-22
-
Price
-
$3.57
Significant Holders of Mind Medicine (MindMed) Inc. - Common Shares (MNMD) as of Q2 2023
93 filings reported holding MNMD - Mind Medicine (MindMed) Inc. - Common Shares as of Q2 2023.
Mind Medicine (MindMed) Inc. - Common Shares (MNMD) has 76 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 3.89M shares
of 80.1M outstanding shares and own 4.86% of the company stock.
Largest 10 shareholders include Alyeska Investment Group, L.P. (797K shares), VANGUARD GROUP INC (568K shares), BlackRock Inc. (553K shares), GEODE CAPITAL MANAGEMENT, LLC (371K shares), Busey Wealth Management (244K shares), CHARLES SCHWAB INVESTMENT MANAGEMENT INC (180K shares), Cresset Asset Management, LLC (159K shares), TWO SIGMA INVESTMENTS, LP (158K shares), STATE STREET CORP (122K shares), and Data Collective IV GP, LLC (100K shares).
This table shows the top 76 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.